膀胱癌幸存者的戒烟策略模式和对电子烟危害的认知 1

IF 1 4区 医学 Q4 ONCOLOGY Bladder Cancer Pub Date : 2024-02-19 DOI:10.3233/blc-230093
Jobin Chandi, Srinath Soundararajan, William Bukowski, Wes Britt, Kristin Weiss, Richard S. Matulewicz, Hannah Kay, Adam O. Goldstein, Kimberly A. Shoenbill, Marc A. Bjurlin
{"title":"膀胱癌幸存者的戒烟策略模式和对电子烟危害的认知 1","authors":"Jobin Chandi, Srinath Soundararajan, William Bukowski, Wes Britt, Kristin Weiss, Richard S. Matulewicz, Hannah Kay, Adam O. Goldstein, Kimberly A. Shoenbill, Marc A. Bjurlin","doi":"10.3233/blc-230093","DOIUrl":null,"url":null,"abstract":"<h4><span>Abstract</span></h4><h3><span></span>BACKGROUND:</h3><p>\nCigarette smoking is the leading preventable cause of bladder cancer (BC). Some proponents of e-cigarettes describe their use as a risk mitigation strategy despite potential carcinogen exposure and uncertain long-term risks.</p><h3><span></span>OBJECTIVE:</h3><p>\nWe assessed smoking cessation strategies, including e-cigarette use, and harm perception among patients with BC.</p><h3><span></span>METHODS:</h3><p>\nWe performed a cross-sectional study on a convenience sample of patients with BC at a single institution from August 2021 –October 2022. The survey instrument was sourced from the Cancer Patient Tobacco Use Questionnaire (C-TUQ) from the American Association for Cancer Research with standardized questions on tobacco use, cessation questions, and e-cigarette harm perceptions.</p><h3><span></span>RESULTS:</h3><p>Of the 104 surveyed BC patients (mean age: 72 years; 27% female; 55% with muscle-invasive disease), 20% were current smokers (median pack years: 40) and 51% were former smokers (median pack years: 20). A minority (9%) had quit smoking at the time of diagnosis. Pharmacotherapy for smoking cessation included nicotine patches (25%), gum (21%), lozenges (8%), e-cigarettes (8%), and Varenicline/Bupropion (4%). Notably, 43% of patients who continued to smoke expressed willingness to switch to e-cigarettes as a cessation aid. E-cigarette users (11%) more commonly perceived e-cigarettes as non-harmful compared to former (4%) and non-smokers (4%) (<i>P</i> = .048), though all groups regarded e-cigarettes as equally addictive as traditional cigarettes.</p><h3><span></span>CONCLUSIONS:</h3><p>\nDespite the prevalence of BC survivors who continue to smoke, a significant proportion perceive e-cigarettes as a viable and less harmful cessation aid. The infrequent use of FDA-approved pharmacotherapies underscores potential implementation gaps. These findings highlight the need for further research and targeted interventions in addressing smoking cessation among BC survivors.</p>","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"262 1","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2024-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Patterns of Smoking Cessation Strategies and Perception of E-cigarette Harm Among Bladder Cancer Survivors 1\",\"authors\":\"Jobin Chandi, Srinath Soundararajan, William Bukowski, Wes Britt, Kristin Weiss, Richard S. Matulewicz, Hannah Kay, Adam O. Goldstein, Kimberly A. Shoenbill, Marc A. Bjurlin\",\"doi\":\"10.3233/blc-230093\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h4><span>Abstract</span></h4><h3><span></span>BACKGROUND:</h3><p>\\nCigarette smoking is the leading preventable cause of bladder cancer (BC). Some proponents of e-cigarettes describe their use as a risk mitigation strategy despite potential carcinogen exposure and uncertain long-term risks.</p><h3><span></span>OBJECTIVE:</h3><p>\\nWe assessed smoking cessation strategies, including e-cigarette use, and harm perception among patients with BC.</p><h3><span></span>METHODS:</h3><p>\\nWe performed a cross-sectional study on a convenience sample of patients with BC at a single institution from August 2021 –October 2022. The survey instrument was sourced from the Cancer Patient Tobacco Use Questionnaire (C-TUQ) from the American Association for Cancer Research with standardized questions on tobacco use, cessation questions, and e-cigarette harm perceptions.</p><h3><span></span>RESULTS:</h3><p>Of the 104 surveyed BC patients (mean age: 72 years; 27% female; 55% with muscle-invasive disease), 20% were current smokers (median pack years: 40) and 51% were former smokers (median pack years: 20). A minority (9%) had quit smoking at the time of diagnosis. Pharmacotherapy for smoking cessation included nicotine patches (25%), gum (21%), lozenges (8%), e-cigarettes (8%), and Varenicline/Bupropion (4%). Notably, 43% of patients who continued to smoke expressed willingness to switch to e-cigarettes as a cessation aid. E-cigarette users (11%) more commonly perceived e-cigarettes as non-harmful compared to former (4%) and non-smokers (4%) (<i>P</i> = .048), though all groups regarded e-cigarettes as equally addictive as traditional cigarettes.</p><h3><span></span>CONCLUSIONS:</h3><p>\\nDespite the prevalence of BC survivors who continue to smoke, a significant proportion perceive e-cigarettes as a viable and less harmful cessation aid. The infrequent use of FDA-approved pharmacotherapies underscores potential implementation gaps. These findings highlight the need for further research and targeted interventions in addressing smoking cessation among BC survivors.</p>\",\"PeriodicalId\":54217,\"journal\":{\"name\":\"Bladder Cancer\",\"volume\":\"262 1\",\"pages\":\"\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2024-02-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bladder Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3233/blc-230093\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bladder Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3233/blc-230093","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

摘要背景:吸烟是膀胱癌(BC)的主要可预防原因。目的:我们评估了 BC 患者的戒烟策略(包括使用电子烟)和危害感知。方法:我们在 2021 年 8 月至 2022 年 10 月期间对一家机构的 BC 患者进行了一项横断面研究。结果:在接受调查的104名BC患者(平均年龄:72岁;27%为女性;55%患有肌肉浸润性疾病)中,20%为当前吸烟者(中位吸烟年数:40包),51%为曾经吸烟者(中位吸烟年数:20包)。少数患者(9%)在确诊时已戒烟。戒烟药物疗法包括尼古丁贴片(25%)、口香糖(21%)、含片(8%)、电子烟(8%)和伐尼克兰/安非他酮(4%)。值得注意的是,43% 继续吸烟的患者表示愿意改用电子烟作为戒烟辅助工具。与曾经吸烟者(4%)和不吸烟者(4%)相比,电子烟使用者(11%)更普遍认为电子烟无害(P = .048),尽管所有群体都认为电子烟与传统香烟一样容易上瘾。美国食品和药物管理局(FDA)批准的药物疗法使用频率较低,这凸显了潜在的实施差距。这些研究结果突出表明,有必要进一步开展研究并采取有针对性的干预措施,以解决巴氏癌幸存者的戒烟问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Patterns of Smoking Cessation Strategies and Perception of E-cigarette Harm Among Bladder Cancer Survivors 1

Abstract

BACKGROUND:

Cigarette smoking is the leading preventable cause of bladder cancer (BC). Some proponents of e-cigarettes describe their use as a risk mitigation strategy despite potential carcinogen exposure and uncertain long-term risks.

OBJECTIVE:

We assessed smoking cessation strategies, including e-cigarette use, and harm perception among patients with BC.

METHODS:

We performed a cross-sectional study on a convenience sample of patients with BC at a single institution from August 2021 –October 2022. The survey instrument was sourced from the Cancer Patient Tobacco Use Questionnaire (C-TUQ) from the American Association for Cancer Research with standardized questions on tobacco use, cessation questions, and e-cigarette harm perceptions.

RESULTS:

Of the 104 surveyed BC patients (mean age: 72 years; 27% female; 55% with muscle-invasive disease), 20% were current smokers (median pack years: 40) and 51% were former smokers (median pack years: 20). A minority (9%) had quit smoking at the time of diagnosis. Pharmacotherapy for smoking cessation included nicotine patches (25%), gum (21%), lozenges (8%), e-cigarettes (8%), and Varenicline/Bupropion (4%). Notably, 43% of patients who continued to smoke expressed willingness to switch to e-cigarettes as a cessation aid. E-cigarette users (11%) more commonly perceived e-cigarettes as non-harmful compared to former (4%) and non-smokers (4%) (P = .048), though all groups regarded e-cigarettes as equally addictive as traditional cigarettes.

CONCLUSIONS:

Despite the prevalence of BC survivors who continue to smoke, a significant proportion perceive e-cigarettes as a viable and less harmful cessation aid. The infrequent use of FDA-approved pharmacotherapies underscores potential implementation gaps. These findings highlight the need for further research and targeted interventions in addressing smoking cessation among BC survivors.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Bladder Cancer
Bladder Cancer Medicine-Urology
CiteScore
1.60
自引率
0.00%
发文量
35
期刊介绍: Bladder Cancer is an international multidisciplinary journal to facilitate progress in understanding the epidemiology/etiology, genetics, molecular correlates, pathogenesis, pharmacology, ethics, patient advocacy and survivorship, diagnosis and treatment of tumors of the bladder and upper urinary tract. The journal publishes research reports, reviews, short communications, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that expedites our fundamental understanding and improves treatment of tumors of the bladder and upper urinary tract.
期刊最新文献
A Molecular Urine Assay to Detect Recurrences During Surveillance of High-Risk Non-Muscle Invasive Bladder Cancer. Challenging Cases in Urothelial Cancer: Case 33. Do All Low Risk Microhematuria Patients Require Cystoscopy? Eligibility and Endpoints for Clinical Trials in Trimodality Therapy for Bladder Cancer. Lifestyle Advice to Patients with Bladder Cancer: A National Survey of Dutch Urologists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1